Room PHS 5B001, European Parliament, Brussels, Belgium
The Avicenna Alliance is proud to announce that it will be supporting the organisation of a large-scale international conference in the European Parliament presenting the newest developments of in silico medicine. The conference will have a global dimension bringing together speakers from e.g. the EU, the USA, and India.
The collective work of Avicenna members from around the world will be showcased. Speakers including EU policy makers and a representative from the FDA will also present key insights on their perspectives on computer modelling and simulation in healthcare.
With in silico offering an understanding of complexity on a scale never before known in human history, the concept of the right treatment for the right patient at the right time no longer becomes an aspiration – it becomes standard practice.
‘In the 1st year of operation the Alliance has the European Commission, FDA and the European Parliament all at the same table getting involved in this discussion’ MEP Seán Kelly (EPP, Ireland) ‘FDA has recognized an important role for Modeling and Simulation to advance regulatory science and its strategic priorities’ Dr. Tina Morrison, U.S. Food and Drug Administration ‘We need input from researchers, industry, doctors, patients and stakeholders to ensure the legal framework fits the purpose’ MEP Nicola Caputo (S&D, Italy) ‘The VPH will revolutionize the way health knowledge is produced, stored and managed and in which healthcare is currently delivered’ European Commission
#InSilico2018
PROGRAMME
04th September 2018, 15:00-17:00
Room PHS 5B001, European Parliament, Brussels
15.00 – 15:10
Introduction by Chairs
Lieve Wierinck, Member of the European Parliament (ALDE, Belgium)
15:10 – 15:40
In silico medicine and the Avicenna Alliance: Making Medicine Modern
Thierry Marchal, Secretary General, Avicenna Alliance
Michael Hill, VP Science, Technology and Clinical Affairs, Medtronic
Geena Malhotra, Global Head of Integrated Product Development, Cipla
15:40 – 15:50
V&V40 EU – Verification and Validation in CM&S of Medical Devices
Tina M. Morrison, Deputy Director, Division of Applied Mechanics and Chair of Modeling and Simulation Working Group, FDA
15:50 – 16:15
Feedback and questions from Participants
Dr. Adriano Henney, Chairman of the Board, Avicenna Alliance
16:15 – 16:25
CM&S and medicinal products’ lifecycle
Dr. Ingrid Klingmann, European Forum for Good Clinical Practice
16:25 – 16:50
Feedback and questions from Participants
Dr. Adriano Henney, Chairman of the Board, Avicenna Alliance
16:50 – 17:00
Closing remarks and next steps by Co-Chairs
Lieve Wierinck, Member of the European Parliament (ALDE, Belgium)
17:00 – 18:00
Networking reception and Q&A with speakers
Speakers
Adriano Henney, PhD
Chairman of the Board of the Avicenna Alliance
Dr Henney has a PhD in Medicine with research interests cardiovascular disease at the pathological, …
READ BIO
Geena Malhotra
Global Head of Integrated Product Development, Cipla
Geena Malhotra is the Global President of Integrated Research & Development and also is a part of …
READ BIO
Ingrid Klingmann, MD, PhD, FFPM, FBCPM
European Forum for Good Clinical Practice (EFGCP), PHARMAPLEX bvba
Physician, specialized in General Medicine, Clinical Pharmacology and Pharmaceutical Medicine with …
READ BIO
Lieve Wierinck
Member of the European Parliament
Lieve Wierinck is a Flemish politician for the liberal Open VLD party. Mrs. Wierinck holds a …
READ BIO
Michael R.S. Hill, PhD, MBA
Vice President Corporate Science, Technology and Clinical Affairs, Medtronic
Michael Hill joined Medtronic in July 1992 as a Scientist in the Cardiac Rhythm Management division …
READ BIO
Thierry Marchal
Avicenna Alliance President and Secretary General
Program Director for Healthcare Solution, ANSYS, Inc.
